11:14 am Immunomedics announces issuance of U.S. Patent which protects a method of concentrating antibodies for subcutaneous, intramuscular or transdermal administration
View todays social media effects on IMMU
View the latest stocks trending across Twitter. Click to view dashboard
See who Immunomedics is hiring next, click here to view
